Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Variables in Cataract Surgery
NCT00407017Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in post-operative inflammation and post-operative infection comparing Kit 1 (Gatifloxacin/Ketorolac/Pred Forte) with Kit 2 (Moxifloxacin/Nepafenac/EconoPred) (2 arms). Status: completed.
02
Drugs
gatifloxacinketorolacmoxifloxacinnepafenacprednisolone
03
Conditions
post-operative inflammationpost-operative infection
Beyond the preview
Go deeper on NCT00407017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407017.